The Arthritis Society / La Société d'Arthrite
Registration:
2
of
33
(2008-07-02
to
2009-04-01)
Legislative Proposal, Bill or Resolution, Regulation
- to monitor the development of new legislation related to medicines, such as Bill C-51, and as appropriate promote timely and transparent approval processes, and effective post-marketing surveillance
Policies or Program
- amend the current Employment Insurance sickness benefit period to better reflect the needs of Canadians with episodic disabilities
- procedures for the special access programs for medicines will not create barriers that prevent people with arthritis from benefiting from this program
- promote a more flexible approach to the current contribution rule for Canada Pension Plan-Disability
- promote an increase in funding for research related to arthritis
- promote changes to the Common Drug Review process to minimize duplication, improve timeliness and transparancy, and encourage the amendment of guidelines to make comparisons of benefits and risks more meaningful to people with arthritis.
- promote the enhancement of federal policy and programs targeted to monitoring arthritis and its impact, and to addressing those impacts through advocating with the Public Health Agency of Canada for the timely release of 'Arthritis in Canada'.
- revise the terms “severe and prolonged” in section 42 of the Canada Pension Plan